Stock Events

Stock Events

Contineum Therapeutics (CTNM) Q2 2026 Earnings

May 5Confirmed

Q2 2025

Q3 2025

Q4 2025

Q2 2026

-0.62

-0.54

-0.47

-0.39

Details

Expected EPS

-0.531929

Actual EPS

-0.39

Surprise EPS

0.14

Surprise Percent

+26.68%

Description

⁨Contineum Therapeutics⁩ (⁦CTNM⁩) has reported earnings of ⁦-0.39⁩ per share for ⁦Q2 2026⁩.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.